232
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Withdrawal and Misuse Concerns of Consumers regarding Opioid Analgesic and Anxiolytic, Hypnotic and Sedative Medicines

ORCID Icon, , ORCID Icon & ORCID Icon

References

  • Alderman, C. P., & Ryan, M. J. (1997). Consumer requests for information regarding psychotropic drugs: Experience from a national medicines phone-in. The Annals of Pharmacotherapy, 31(11), 1301–1305. https://doi.org/10.1177/106002809703101104
  • Anker, A. E., Reinhart, A. M., & Feeley, T. H. (2011). Health information seeking: A review of measures and methods. Patient ducation and Counseling, 82(3), 346–354. https://doi.org/10.1016/j.pec.2010.12.008
  • Australian Bureau of Statistics. (2012). Year book Australia 2012. ABS.
  • Australian Bureau of Statistics. (2016). Patterns of use of mental health services and prescription medications, 2011 (4329.0.00.003). Canberra: ABS. Retrieved from https://www.abs.gov.au/ausstats/[email protected]/Lookup/by%20Subject/4329.0.00.003∼2011∼Main%20Features∼Introduction∼1
  • Australian Institute of Health and Welfare. (2018). Opioid harm in Australia and comparisons between Australia and Canada (Cat. no. HSE 210). AIHW.
  • Bartlett, R., Brown, L., Shattell, M., Wright, T., & Lewallen, L. (2013). Harm reduction: Compassionate care of persons with addictions. Medsurg Nursing: official Journal of the Academy of Medical-Surgical Nurses, 22(6), 349–358.
  • Bazeley, P. (2009). Analysing qualitative data: More than ‘identifying themes’ Malaysian. Journal of Qualitative Research, 2(2), 6–22.
  • Berry, D., Michas, I., & Bersellini, E. (2002). Communicating information about medication side effects: Effects on satisfaction, perceived risk to health, and intention to comply. Psychology & Health, 17(3), 247–267. https://doi.org/10.1080/08870440290029520a
  • Berry, D., Michas, I., Gillie, T., & Forster, M. (1997). What do patients want to know about their medicines, and what do doctors want to tell them?: A comparative study. Psychology & Health, 12(4), 467–480.
  • Blake, S., Ruel, B., Seamark, C., & Seamark, D. (2007). Experiences of patients requiring strong opioid drugs for chronic non-cancer pain: A patient-initiated study. The British Journal of General Practice: The Journal of the Royal College of General Practitioners, 57(535), 101–108. https://doi.org/10.3399/bjgp13X675403
  • Blanch, B., Pearson, S., & Haber, P. (2014). An overview of the patterns of prescription opioid use, costs and related harms in Australia. British Journal of Clinical Pharmacology, 78(5), 1159–1166. https://doi.org/10.1111/bcp.12446
  • Brashers, D. E. (2001). Communication and uncertainty management. Journal of Communication, 51(3), 477–497. https://doi.org/10.1111/j.1460-2466.2001.tb02892.x
  • Britten, N. (2009). Medication errors: The role of the patient. British Journal of Clinical Pharmacology, 67(6), 646–650. https://doi.org/10.1111/j.1365-2125.2009.03421.x
  • Britten, N., Stevenson, F. A., Barry, C. A., Barber, N., & Bradley, C. P. (2000). Misunderstandings in prescribing decisions in general practice: Qualitative study. BMJ (Clinical Research ed.), 320(7233), 484–488. https://doi.org/10.1136/bmj.320.7233.484
  • Clark, D. J., & Schumacher, M. A. (2017). America's opioid epidemic: Supply and demand considerations. Anesthesia and Analgesia, 125(5), 1667–1674. https://doi.org/10.1213/ANE.0000000000002388
  • Clarke, M. A., Moore, J. L., Steege, L. M., Koopman, R. J., Belden, J. L., Canfield, S. M., Meadows, S. E., Elliott, S. G., & Kim, M. S. (2016). Health information needs, sources, and barriers of primary care patients to achieve patient-centered care: A literature review. Health nformatics Informatics Journal, 22(4), 992–1016. https://doi.org/10.1177/1460458215602939
  • Commonwealth Department of Health and Aged Care. (1999). The national medicines policy. Canberra: Publications Production Unit.
  • Commonwealth Department of Health and Aged Care National Key Centre for Social Applications of Geographical Information Systems. (2001). Measuring remoteness: Accessibility/Remoteness Index of Australia (ARIA) (Revised ed.).  Canberra: Commonwealth Department of Health and Aged Care.
  • Conrardy, M., Lank, P., Cameron, K. A., McConnell, R., Chevrier, A., Sears, J., Ahlstrom, E., Wolf, M. S., Courtney, D. M., & McCarthy, D. M. (2016). Emergency department patient perspectives on the risk of addiction to prescription opioids. Pain Medicine (Malden, Mass.), 17(1), 114–121. https://doi.org/10.1111/pme.12862
  • Cooper, S., Campbell, G., Larance, B., Murnion, B., & Nielsen, S. (2018). Perceived stigma and social support in treatment for pharmaceutical opioid dependence. Drug and lcohol Review, 37(2), 262–272. https://doi.org/10.1111/dar.12601
  • Corcoran, T. B., Haigh, F., Seabrook, A., & Schug, S. A. (2009). The quality of internet-sourced information for patients with chronic pain is poor. The Clinical Journal of Pain, 25(7), 617–623. https://doi.org/10.1097/AJP.0b013e3181a5b5d5
  • Dell’Osso, B., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F.,Del Vecchio V, Di Nicola M, Ferrari S, Goracci A, Iasevoli F, Luciano M, Martinotti G, Nanni MG, Nivoli A, Pinna F, Poloni N, Pompili M, Sampogna G, Tarricone I, Tosato S, Volpe U, Fiorillo A. (2015). Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric Disease and Treatment, 11, 1885–1909.
  • Dutta-Bergman, M. J. (2003). Developing a profile of consumer intention to seek our health information beyond a doctor. Health arketing Mark Q, 21(1–2), 91–112. https://doi.org/10.1300/J026v21n01_05
  • ElectronicTherapeutic Guidelines (eTG) complete. (2019). Chronic pain: pharmacological management. Therapeutic Guidelines Ltd.
  • Fields, H. L. (2011). The Doctor's dilemma: Opiate analgesics and chronic pain. Neuron, 69(4), 591–594. https://doi.org/10.1016/j.neuron.2011.02.001
  • Gisev, N., Pearson, S.-A., Karanges, E. A., Larance, B., Buckley, N. A., Larney, S., Dobbins, T., Blanch, B., & Degenhardt, L. (2018). To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia? Pharmacoepidemiology and Drug Safety, 27(5), 550–555. https://doi.org/10.1002/pds.4329
  • Hollingworth, S. A., Gray, P. D., Hall, W. D., & Najman, J. M. (2015). Opioid analgesic prescribing in Australia: A focus on gender and age. Pharmacoepidemiology and Drug Safety, 24(6), 628–636. https://doi.org/10.1002/pds.3767
  • Hollingworth, S. A., & Siskind, D. J. (2010). Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiology and Drug Safety, 19(3), 280–288. https://doi.org/10.1002/pds.1899
  • Lader, M., & Kyriacou, A. (2016). Withdrawing benzodiazepines in patients with anxiety disorders. Current Psychiatry Reports, 18(1), 8. https://doi.org/10.1007/s11920-015-0642-5
  • Lambert, S. D., & Loiselle, C. G. (2007). Health information seeking behavior. Qualitative Health Research, 17(8), 1006–1019. https://doi.org/10.1177/1049732307305199
  • Larance, B., Campbell, G., Moore, T., Nielsen, S., Bruno, R., Lintzeris, N., Cohen, M., Hall, W., Mattick, R., O'Donnell, C., & Degenhardt, L. (2019). Concerns and help-seeking among patients using opioids for management of chronic noncancer pain. Pain Medicine (Malden, Mass.), 20(4), 758–769. https://doi.org/10.1093/pm/pny078
  • Lau, S. M., McGuire, T. M., & van Driel, M. L. (2016). Consumer concerns about paracetamol: A retrospective analysis of a medicines call centre. BMJ Open, 6(6), e010860. https://doi.org/10.1136/bmjopen-2015-010860
  • Lembke, A., Papac, J., & Humphreys, K. (2018). Our other prescription drug problem. The New England Journal of Medicine, 378(8), 693–695. https://doi.org/10.1056/NEJMp1715050
  • Lewis, E. T., Combs, A., & Trafton, J. A. (2010). Reasons for under-use of prescribed opioid medications by patients in pain. Pain Medicine (Malden, Mass.), 11(6), 861–871. https://doi.org/10.1111/j.1526-4637.2010.00868.x
  • Liebrenz, M., Gehring, M. T., Buadze, A., & Caflisch, C. (2015). High-dose benzodiazepine dependence: A qualitative study of patients' perception on cessation and withdrawal. BMC Psychiatry, 15, 116. https://doi.org/10.1186/s12888-015-0493-y
  • Mackenzie, C. S., Gekoski, W. L., & Knox, V. J. (2006). Age, gender, and the underutilization of mental health services: The influence of help-seeking attitudes. Aging & Mental Health, 10(6), 574–582. https://doi.org/10.1080/13607860600641200
  • Maiti, R., & Alloza, J. L. (2014). Social pharmacology: Expanding horizons. Indian Journal of Pharmacology, 46(3), 246–250. https://doi.org/10.4103/0253-7613.132151
  • Maree, R. D., Marcum, Z. A., Saghafi, E., Weiner, D. K., & Karp, J. F. (2016). A systematic review of opioid and benzodiazepine misuse in older adults. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 24(11), 949–963. https://doi.org/10.1016/j.jagp.2016.06.003
  • McCarthy, D. M., Cameron, K. A., King, J. P., Mullen, R. J., Bailey, S. C., Jacobson, K. L., Di Francesco, L., Davis, T. C., Parker, R. M., & Wolf, M. S. (2014). Patient recall of health care provider counseling for opioid-acetaminophen prescriptions. Pain Medicine (Malden, Mass.), 15(10), 1750–1756. https://doi.org/10.1111/pme.12499
  • Narhi, U., & Helakorpi, S. (2007). Sources of medicine information in Finland. Health Policy, 84(1), 51–57. https://doi.org/10.1016/j.healthpol.2007.05.005
  • Newby, D. A., Hill, S. R., Barker, B. J., Drew, A. K., & Henry, D. A. (2001). Drug information for consumers: Should it be disease or medication specific? Results of a community survey. Australian and New Zealand Journal of Public Health, 25(6), 564–570. https://doi.org/10.1111/j.1467-842x.2001.tb00327.x
  • Nicholas, R., Lee, N., & Roche, A. (2018). Pharmaceutical drug misuse in australia: complex problems, balanced responses., 2011. National Centre for Education and Training on Addiction (NCETA). Retrieved from http://nceta.flinders.edu.au/files/6113/2823/3742/EN448_Nicholas_2011.pdf
  • Norrbrink, C., Lofgren, M., Hunter, J. P., & Ellis, J. (2012). Patients' perspectives on pain. Topics in Spinal Cord Injury Rehabilitation, 18(1), 50–56. https://doi.org/10.1310/sci1801-50
  • Pache, D. M., Hollingworth, S. A., van Driel, M. L., & McGuire, T. M. (2019). Does consumer medicines interest reflect medicines use? An observational study comparing medicines call center queries with medicines use. Research in Social & Administrative Pharmacy: RSAP, 15(4), 440–447. https://doi.org/10.1016/j.sapharm.2018.06.012
  • Pohjanoksa-Mantyla, M., Antila, J., Eerikainen, S., Enakoski, M., Hannuksela, O., Pietila, K., & Airaksinen, M. (2008). Utilization of a community pharmacy-operated national drug information call center in Finland. Research in Social & Administrative Pharmacy: RSAP, 4(2), 144–152. https://doi.org/10.1016/j.sapharm.2007.05.001
  • Pohjanoksa-Mantyla, M., Bell, J. S., Helakorpi, S., Narhi, U., Pelkonen, A., & Airaksinen, M. S. (2011). Is the internet replacing health professionals? A population survey on sources of medicines information among people with mental disorders. Social Psychiatry and Psychiatric Epidemiology, 46(5), 373–379. https://doi.org/10.1007/s00127-010-0201-7
  • Rains, S. A., & Tukachinsky, R. (2015). Information seeking in uncertainty management theory: Exposure to information about medical uncertainty and information-processing orientation as predictors of uncertainty management success. Journal of Health Communication, 20(11), 1275–1286. https://doi.org/10.1080/10810730.2015.1018641
  • Rapport, F. L., Jerzembek, G. S., Doel, M. A., Jones, A., Cella, M., & Lloyd, K. R. (2010). Narrating uncertainties about treatment of mental health conditions. Social Psychiatry and Psychiatric Epidemiology, 45(3), 371–379. https://doi.org/10.1007/s00127-009-0072-y
  • Schulden, J. D., Lopez, M. F., & Compton, W. M. (2012). Clinical implications of drug abuse epidemiology. The Psychiatric Clinics of North America, 35(2), 411–423. https://doi.org/10.1016/j.psc.2012.03.007
  • Slade, T., Johnston, A., Teesson, M., Whiteford, H., Burgess, P., & Pirkis, J. (2007). The Mental Health of Australians 2. Report on the 2007 National Survey of Mental Health and Wellbeing. Department of Health and Ageing, Canberra.
  • Smith, J. A., Braunack-Mayer, A., & Wittert, G. (2006). What do we know about men’s help-seeking and health service use? The Medical Journal of Australia, 184(2), 81–83. https://doi.org/10.5694/j.1326-5377.2006.tb00124.x
  • Stephenson, C. P., Karanges, E., & McGregor, I. S. (2013). Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. The Australian and New Zealand Journal of Psychiatry, 47(1), 74–87. https://doi.org/10.1177/0004867412466595
  • Upshur, C. C., Bacigalupe, G., & Luckmann, R. (2010). They don't want anything to do with you": Patient views of primary care management of chronic pain. Pain Medicine, 11(12), 1791–1798. https://doi.org/10.1111/j.1526-4637.2010.00960.x
  • von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gotzsche, P. C., & Vandenbroucke, J. P., STROBE Initiative. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ (Clinical Research ed.), 335, 806–808. https://doi.org/10.1136/bmj.39335.541782.AD
  • Weersink, R. A., Taxis, K., McGuire, T. M., & van Driel, M. L. (2015). Consumers' questions about antipsychotic medication: Revealing safety concerns and the silent voices of young men. Social Psychiatry and Psychiatric Epidemiology, 50(5), 725–733. https://doi.org/10.1007/s00127-014-1005-y
  • World Health Organization. (2017). WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. WHO.
  • Yap, M. B. H., Reavley, N., & Jorm, A. F. (2013). Where would young people seek help for mental disorders and what stops them? Findings from an Australian national survey. Journal of Affective Disorders, 147(1–3), 255–261. https://doi.org/10.1016/j.jad.2012.11.014
  • Young, H. N., Bell, R. A., Epstein, R. M., Feldman, M. D., & Kravitz, R. L. (2006). Types of information physicians provide when prescribing antidepressants. Journal of General Internal Medicine, 21(11), 1172–1177. https://doi.org/10.1111/j.1525-1497.2006.00589.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.